Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
orBec for Upper GI Symptoms in Chronic GI GVHD
NCT01925950Phase 2Terminated
- Sponsor
- Soligenix
- Start
- Dec 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beclomethasone dipropionate in chronic graft-versus-host disease (cGVHD), sponsored by Soligenix. Started Dec 2013; status: terminated.
02
Drugs
beclomethasone dipropionate
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01925950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01925950.